中医药对食管癌患者化疗毒副反应及生活质量的影响
袁金艳，刘小玲，马甜
（陕西省人民医院，陕西 西安，710068）
浏览次数：209次 下载次数：433次
摘要：
目的 分析中医药对食管癌患者化疗毒副反应及生活质量的影响。方法 回顾性分析我院2014年3月至2015年3月收治的130例食管癌患者的病历资料，将130 例食管癌患者按治疗方式不同分为对照组和观察组，各65例。两组患者都运用化疗方案，观察组患者加用中医药治疗，两组患者均进行两个周期的治疗，对患者的临床疗效进行比较，并观察两组患者毒 副反应及生活质量情况。结果 两组患者的临床疗效比较，无显著差异（x²=1.14，P>0.05）；观察组患者毒副反应发生率明显低于对照组，差异有统计学意义（x²=10.214，P<0.05）；观察组患者治疗后生活质量评分明显高于对照组（t=38.44，P<0.05）。结论 中医药联合化疗治疗食管癌患者，不仅可以降低患者化疗毒副反应，同时也能提高患者生活质量，临床应用价值较高。
关键词：中医药；食管癌；化疗；毒副反应；生活质量
中图分类号：R735.1文献标志码：A文章编号：2096-1413(2017)01-0100-02
The influence of Chinese medicine on the side effects of chemotherapy and quality of life in
patients with esophageal cancer
YUAN Jin-yan, Liu Xiao-ling, Ma Tian
(Shaanxi Provincial People s Hospital, Xi an 710068, China)
ABSTRACT: Objective To study the effect of Chinese medicine on the side effects of chemotherapy and quality of life in patients with esophageal cancer. Methods Retrospectively analyze 130 cases of esophageal cancer patients in our hospital from March 2014 to March 2015 and 130 cases of esophageal cancer patients were randomly divided into control group and observation group, with 65 cases in each group. Both of the two group were given chemotherapy, otherwise, the observation group was treated with traditional Chinese medicine. The patients in two groups were treated with two cycles, the clinical efficacy of the patients were compared and analyzed, and the adverse reactions and quality of life in two groups were compared. Results The comparison of clinical efficacy of the two groups had no significant difference ( X 2=1.235, P>0.05); The incidence rate of adverse reactions in observation group were significantly lower than that of the control group ( X2=10.214, P<0.05). After treatment, the quality of life in the observation group was significantly higher than that of the control group ( X 2 =38.44, P<0.05). Conclusion Chinese medicine combined with chemotherapy for esophageal cancer patients not only can reduce the side effects of chemotherapy, but also improve the quality of life of patients, which has a high clinical application value.
KEYWORDS: traditional Chinese medicine; esophageal cancer; chemotherapy; toxicity; life quality
参考文献：
[1] 宋希荣.中药对中晚期食管癌化疗毒副反应的影响[J].中国医学创新,2013,10(17):50-51.
[2] 陈月琴,高凤兰,李燕辉,等.护理干预对食管癌患者同步放化疗临床疗效的影响[J].中国中医药现代远程教育,2013,11(8):108-110.
[3] 高侃,魏东,耿惠,等.碎岩散联合化疗治疗气虚阳微型食管癌43例临床观察[J].河北中医药学报,2012,27(2):17-18.
[4] 严卿莹,张恺,阮善明,等.中医药治疗中晚期食管癌疗效的Meta 分析[J].浙江中医药大学学报,2015,39(1):43-50.
[5] 周雷,李智强,徐彬,等.周剂量化疗联合放疗治疗中晚期食管癌疗效观察[J].中国中医药科技,2014,4(z2):204.
[6] 刘安家.复方苦参注射液联合放化疗治疗中晚期食管癌的临床观察[J].中国民间疗法,2014,22(10):63-64.
[7] 王赟,谷建钟,傅婷,等.肠内免疫营养对食管癌化疗病人营养状况、血液毒性和免疫功能影响的临床研究[J].肠外与肠内营养,2014,21(2):76-79.
[8] 林清,容景瑜.mFOLFOX6 方案联合消癌平治疗晚期食管癌的疗效观察[J].广西医学,2013,2(7):912-913.
[9] 江鸿杰.食管癌术后的中医药治疗[J].长春中医药大学学报,2011,27(6):967-969.
[10] 顾敏威,孙振宇,王敏锋,等.化疗联合DIK细胞治疗在食管癌的临床应用[J].湖南中医药大学学报,2013,33(12):15.